HLA Class II Haplotypes Predict Favorable Outcomes for Patients With Metastatic RCC
Der Urologe - Germany
doi 10.1007/s00120-004-0603-9
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2004
Authors
Publisher
Springer Nature